InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: Lbjenn post# 87910

Friday, 10/25/2013 9:03:31 AM

Friday, October 25, 2013 9:03:31 AM

Post# of 130503
Great article on LymPro!!! Its cool to see AMBS get some love (from Seeking Alpha). LymPro appears (and will be) a very serious force in the Alzheimers market space going forward (and will only get more attention as more and more become knowledgeable regarding its capabilities).

Specifically, the article confirms too...that BD is doing the future Phase 2 testing; however, I don't recall that Geralds PR ever confirmed who was doing the next set of testing (which was a very big miss on his part).

In terms of Wall Street; companies need to spin the PR to capture an audience properly. The Zacks (Jason Napodano) and Seeking Alpha folks did a nice job to bring further detail and clarification to marketplace (regarding Lympro and the potential of MANF).

Lastly, I really do think the PPS is a strong buy down here at $.05; and that assumes that the investor/investors who did the most recent financing tranche have unloaded majority of their shares (which they would have still booked a very nice profit).

GLTA!!!